Hypoxic-Ischemic Encephalopathy: Changing Outcomes Across the Spectrum.

Area of Science:

• Neonatal neurology
• Perinatal medicine
• Neurocritical care

Background:

• Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of infant death and disability.
• Therapeutic hypothermia (TH) is the sole proven treatment for moderate-to-severe HIE, reducing mortality and impairment.
• Infants with mild HIE were historically excluded from trials, assuming lower risk.

Purpose of the Study:

• To review the evolving role of therapeutic hypothermia in HIE management.
• To examine the spectrum of HIE presentations.
• To discuss neurodevelopmental outcomes across the HIE severity spectrum.

Main Methods:

• Literature review of recent studies on HIE and therapeutic hypothermia.
• Analysis of neurodevelopmental outcomes in infants with varying HIE severity.
• Focus on updated evidence regarding mild HIE cases.

Main Results:

• Randomized trials confirm TH efficacy in moderate-to-severe HIE.
• Emerging data indicate significant neurodevelopmental risks for infants with mild HIE who do not receive treatment.
• The understanding of HIE's impact is broadening beyond severe cases.

Conclusions:

• The management paradigm for HIE is shifting, potentially including milder cases.
• Further research is needed to define optimal treatment strategies for all HIE severities.
• Recognizing risks in mild HIE is crucial for improving long-term infant neurodevelopmental health.